transform: liso-cel versus standard of care as second-line therapy for r/r lbcl
Published 1 year ago • 51 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
5:04
transform: phase iii study of liso-cel versus standard of care for r/r lbcl
-
2:19
primary analysis of the transform study: liso-cel vs soc as second-line treatment for r/r lbcl
-
2:40
primary analysis of the phase iii transform study: liso-cel in second-line lbcl
-
2:18
matched-adjusted comparison of liso-cel versus axi-cel for the second-line treatment of r/r lbcl
-
2:17
update on transform: liso-cel vs soc in r/r lbcl
-
3:59
3-year follow-up from the transform trial: liso-cel is superior to soc in r/r dlbcl
-
4:53
interim analysis of transform: liso-cel vs soc in high-risk r/r lbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
0:59
matching-adjusted indirect comparison of liso-cel vs axi-cel in the 2l treatment of r/r lbcl
-
4:09
real-world safety and efficacy of liso-cel in r/r large b-cell lymphoma
-
1:17
efficacy & safety of standard of care cilta-cel in r/r multiple myeloma
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
1:02
the changing standard of care in dlbcl
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:31
liso-cel vs tisa-cel in third-line dlbcl treatment
-
1:59
the growing importance of celmods in the treatment of r/r multiple myeloma